A small group of elite investors are behind Uber's latest fundraising effort and believe the company is set for a massive IPO.» Read More
Some of America's biggest and most influential hedge funds are investing heavily in Chinese tech giant Alibaba.
Sotheby’s battle with activist investor Dan Loeb resulted in a special charge of $20.1 million in the first nine months of 2014.
October was a rough month for much of the hedge fund crowd, where many players underperformed the U.S. stock market and wound up with big losses.
After salivating at the Alibaba IPO, hedge fund managers lucky enough to buy in early are indeed getting a nice kick to their returns.
Big name investors like Dan Loeb and David Einhorn helped raise $6 million to fight poverty at a charity event in New York City.
Hedge fund manager Dan Loeb recommended Amgen's stock Tuesday, causing shares to rise on the news.
Larry Robbins of Glenview Capital unveiled four new stock picks at the Robin Hood Investors conference Tuesday.
Wall Street is spending more on the midterms than ever before—particularly in support of the GOP—but it's not from whom you might think.
Founder and CEO, Third Point LLC
Third Point has taken a "significant" position in eBay, a source told CNBC.
Starboard Value sent a letter to Yahoo on Friday listing several opportunities to increase shareholder value and recommending that it merge with AOL.
A recent move by CalPERS was seen as a victory for critics of hedge funds' high fees and low transparency and liquidity.
He bashed rival funds such as Elliott Management, which has invested in Argentine bonds and held out for full payment, calling their behavior immoral.
"I think this is bait for an activist," Ritholtz Wealth Management's Josh Brown says of Yahoo's stock after Alibaba's IPO.
Investors want more of activist hedge fund manager Dan Loeb, and they're putting up lots of cash to prove it.
The hedge fund community appears to be salivating over Alibaba, with interest from Leon Cooperman, Dan Loeb and other major players.
William Ackman criticized Allergan's board of directors, urging them to "wake up" and at least listen to potential purchaser Valeant Pharmaceuticals.
Junk bonds have fallen about 3 percent since their peak, and some traders expect the broader stock market to follow suit—perhaps imminently.
The S&P 500 may have rallied 6 percent during the first half of the year, but the average hedge fund appears to have trailed that substantially.
While these may not be the best of times for hedge funds, they're still pretty good for the best of the best.